GlassScriptPhysician profile
Jacob Manoj Kitchener
NPI 1003818733
$6,336.35
in general payments reported to CMS, 2019-2025
50 companies · $677 in 2025
The $677 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,650 · 2020: $665 · 2021: $908 · 2022: $840 · 2023: $540 · 2024: $1,056 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,273.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $574.94 | 2019-2025 | Penumbra System, Red 72, Penumbra Coil 400 |
| Ucb, INC. | $536.76 | 2019-2025 | Zilbrysq, Nayzilam, Briviact |
| Stryker Corporation | $526.34 | 2019-2023 | Spinejack |
| Supernus Pharmaceuticals, INC. | $509.34 | 2022-2024 | Qelbree |
| Microvention, INC. | $478.66 | 2019-2024 | Sofia 6f-131cm Str, Eric Retrieval Device |
| Novartis Pharmaceuticals Corporation | $459.18 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $356.37 | 2019-2025 | Ultomiris |
| Sk Life Science, INC. | $220.60 | 2020-2023 | |
| Medtronic USA, INC. | $219.38 | 2019 | |
| Biogen, INC. | $203.13 | 2020-2025 | Skyclarys |
| Depuy Synthes Sales INC. | $165.29 | 2019-2020 | |
| Imperative Care, INC | $162.25 | 2022-2025 | Zoom 88-T Large Distal Platform |
| Amgen INC. | $156.20 | 2019-2025 | Uplizna |
| Teva Pharmaceuticals USA, INC. | $152.82 | 2019-2021 | |
| Genentech USA, INC. | $139.21 | 2019-2020 |
Show all 49 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Kitchener listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.